The light at the end of the tunnel is approaching as Operation Warp Speed delivered COVID-19 vaccines to healthcare workers and LTC residents in December 2020. There will certainly be bumps in the road, supply chain delays and allocations, which means that most patients will not be able to receive COVID-19 vaccines until mid- to late 2021.
The federal government has pre-paid for millions of vaccine doses and will be distributing them to health care providers at no cost, which means that when government-supplied vaccine becomes available at community pharmacies, you will not have to pay to acquire it. For vaccine doses supplied by the federal government, pharmacies may NOT charge patients for the vaccine itself, but may bill payers for the administration. The federal government has mandated coverage under Medicare Part B, Medicaid and Commercial insurance with no out-of-pocket costs to patients. The CARES Act also provides for reimbursement for uninsured patients through the Health Resources & Services Administration (HRSA).
|Payer||Coverage and Billing Considerations|
|Medicare Part B||
The coverage for COVID-19 vaccine may be under the pharmacy benefit (via NCPDP standard) or the medical benefit (via CPT codes). Here is a summary of billing information known to PAAS National® as of December 23, 2020.
|Vaccine||NDC-11||Billing Quantity||Days’ Supply||Dose 1||Dose 2|
|Pfizer BioNTech||59267-1000-01||0.3 mL||1||SCC-02 to indicate “first dose”||SCC-06 to indicate “final dose”|
NCPDP also recommends that pharmacy claims will need to submit the following for ZERO-COST vaccines:
- Professional Service Code (440-E5) of “MA” (Medication Administered)
- Ingredient Cost Submitted (409-D9) of $0.00 or $0.01
- Incentive Amount Submitted (438-E3) to request payment for administration (e.g., $16.94 or $28.39)
- Basis of Cost Determination (423-DN) of “15” (free product or no associated cost)